Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

31results about How to "Prove security" patented technology

Carthamus tinctorius L. extract, cosmetic adopting same as active ingredient and application

InactiveCN105193893AImprove utilization function and added valueGood securityCosmetic preparationsToilet preparationsCarthamusActive agent
The invention discloses Carthamus tinctorius L. plant extract, a cosmetic additive adopting the same for realizing skin whitening, moisturizing and antioxidant activity and a combined application of the Carthamus tinctorius L. extract in cosmetics. The Carthamus tinctorius L. extract is ethanol extract of Carthamus tinctorius L. bee pollen or Carthamus tinctorius L. inflorescence or Carthamus tinctorius L. seed oil extract. The extract has good DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical cleaning capacity and is a good natural antioxidant. The Carthamus tinctorius L. extract has excellent skin cosmetic application potential in aspects of wrinkle resisting, whitening, sunscreen and the like in terms of skin care of a human body. With the effective utilization of Carthamus tinctorius L. which is the traditional medicinal plant in China, the Carthamus tinctorius L. extract with very high skin cosmetic activity is obtained, and the extract can be used for preparing a good tyrosinase activity inhibitor and a collagen secretion promoting active agent and is a good raw material for herbal cosmetics.
Owner:KUNMING INST OF BOTANY - CHINESE ACAD OF SCI

Preparation method and application of Thanakha extract

The invention discloses a preparation method of a Thanakha extract and an application of the Thanakha extract in cosmetics. The Thanakha extract is an extract of Thanakha bark. The extract has good DPPH free radical scavenging ability, is a good natural antioxidant, has excellent senility-preventing and whitening functions, and is a good natural plant cosmetic raw material.
Owner:广东创美抗衰老研究有限公司

System safety performance evaluation method based on FDA camouflage spoofing

The invention relates to physical layer information security techniques for wireless communications, and discloses a system safety performance evaluation method based on FDA camouflage spoofing. The method comprises the following steps: step 1, taking a carrier of a certain array element of an FDA antenna as a reference carrier frequency, adding different frequency offsets to carrier frequencies of other array elements on the basis of the reference array element carrier frequency, and then transmitting a signal carrying information through the FDA antenna; 2, enabling a legal user D to designa signal receiver of the legal user D according to the characteristics of a signal transmitter, and to perform information demodulation on the received signal; 3, enabling an eavesdropping user E to judge the signals received by the receiver, and to perform information demodulation on the received signals in an OFDM signal processing mode according to the characteristics of the received signals; and 4, respectively calculating the receiving signal-to-noise ratios of the legal user and the eavesdropping user according to the step 2 and the step 3, and then calculating the safety transmission rate of the system so as to evaluate the safety performance of the system. According to the invention, safe transmission of information is ensured.
Owner:UNIV OF ELECTRONICS SCI & TECH OF CHINA

Traditional Chinese medicine composition for treating migraine, preparation method and application

The invention discloses a traditional Chinese medicine composition for treating migraine, a preparation method and an application. The invention relates to a new traditional Chinese medicine composition for treating migraine, and belongs to the technical field of traditional Chinese medicine. The migraine is headache caused by periodically attacked nerve-vascular function disorder, and the global morbidity of the disease is 14.7%, and domestic morbidity is 732.1/100, 000; meanwhile, migraine is closely related to cerebral infarction, depression and other diseases; the World Health Organization regards it as the one of the most disabling chronic disease. The disease has not special treatment method, and western drug therapy can ease the symptom of a part of patient, but is often accompanied with obvious side effect, the treatment may cause drug addiction and even drug-induced headache. The method of harmonizing nutrient and defense of traditional Chinese medicine has good treatment effect to migraine, can integrally regulate, and is small in side effect, free from drug dependence. The market is lack of new traditional Chinese medicine of treating migraine. Specific to the phase characteristics of migraine, the four-smooth soup is prepared by taking method of harmonizing nutrient and defense as the basis, summarizing experiences, and carefully selecting effective drugs and has good clinical treatment effect to migraine patient with cold tendency or deficiency of yang, and can make up the shortcomings of the existed treatment drug.
Owner:DONGZHIMEN HOSPITAL OF BEIJING UNIV OF CHINESE MEDICINE

Bone repair material as well as preparation method and application thereof

The invention belongs to the field of active protein-containing biomedical materials and the field of regenerative medicine and particularly provides a bone repair material. The bone repair material contains modified chitosan, gelatin and rH-BMP2 (bone morphogenetic protein-2). The material can be used for repairing bone injury. The bone repair material is prepared from the following components inpercentage by mass: 1%-10% of rH-BMP2, 20%-70% of modified chitosan and 20%-70% of gelatin. A tremendous advance is made in degradation / drug release time by using allyltrimethylammonium chloride or acrylamide modified chitosan and gelatin as sustained release carriers, and allergy is reduced substantially. The material has the effects obviously better than those of chitosan and the existing similar materials in in-vitro release tests and animal tests, and safety of the material is proved preliminarily by cytotoxicity tests.
Owner:ZHEJIANG RISING BIOTECH CO LTD

Use of memantine hydrochloride (MEM) to prevention and/or treatment of diseases caused by bacterial infection

The invention discloses use of memantine hydrochloride (MEM) to prevention and / or treatment of diseases caused by bacterial infection. The memantine hydrochloride achieves the sterilization effect through neutrophil and a neutrophil extracellular trap so as to prevent and treat the diseases caused by the bacterial infection. The invention further discloses the use of united usage of the memantinehydrochloride and an antibiotic to preparation of a medicine for preventing and / or treating the diseases caused by the bacterial infection. Cells, a mouse model and the neutrophil extracellular trap are used, techniques of cell invasion, cell migration, mouse bacterial invasion, next-generation sequencing and the like are used, the anti-bacterium action mechanism of the MEM is researched, and through restraining alpha 7nAChR mediation, bacteremia / septicaemia and the diseases caused by the bacterial infection including bacterial meningitis can be effectively blocked.
Owner:黄胜和

System security performance evaluation method based on fda camouflage and deception

The invention relates to physical layer information security technology of wireless communication. The invention discloses a system safety performance evaluation method based on FDA camouflage and deception, comprising the following steps: Step 1: taking the carrier frequency of a certain array element of the FDA antenna as the reference carrier frequency, and the carrier frequency of other array elements as the reference carrier frequency Add different frequency offsets on the basis of the carrier frequency, and then transmit the signal carrying information through the FDA antenna; Step 2: The legal user D designs its signal receiver according to the characteristics of the signal transmitter, and performs information analysis on the received signal step 3: eavesdropping user E judges the signal received by its receiver, and uses OFDM signal processing method according to the characteristics of the received signal to demodulate the received signal; step 4: calculate according to step 2 and step 3 respectively The receiving signal-to-noise ratio of legitimate users and eavesdropping users is calculated, and then the safe transmission rate of the system is calculated to evaluate the system security performance. The invention ensures the safe transmission of information.
Owner:UNIV OF ELECTRONICS SCI & TECH OF CHINA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products